Nonlinear nightmare [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2013-11-26 15:32 (4597 d 10:32 ago) – Posting: # 11972
Views: 17,076

Hi John,

❝ Have you goofed around with DDI before (drug interaction->inhibition)?


Yes, but always in steady state and not with CBZ.

❝ You can't run carbamazepine single dose BE due to autoinduction.


No? Single dose studies are recommended in all of FDA’s carbamazepine-guidances. I don’t think that full autoinduction is seen in the first dose. It will take the enzymes a while to tune up. That’s why I started to play around with time-dependent increase of clearance.

Regulators differ in their opinions whether CBZ is an NTID. Even if the conventional 80–125% are applicable to Cmax and AUC, pAUC would be a sensitive PK metric being able to discriminate between formulations with different absorption rates.

❝ We ran the BE program before and went with multiple-dose studies with no washout period like 8 yrs ago. I hope no one did...


Oh boy…

❝ I don't have Laszlo's paper so I don't know the details.


You’ve got mail. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
378 visitors (0 registered, 378 guests [including 18 identified bots]).
Forum time: 03:04 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5